Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, David Kremer, Bianca Teegen et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 30
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Marc Pawlitzki, Philipp Albrecht et al.|Multiple Sclerosis and Related Disorders|2022Cited by 21
Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitisSaskia Räuber, Nico Melzer, Kristin S. Golombeck et al.|Journal of Autoimmunity|2023Cited by 14
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, David Kremer, Kristin S. Golombeck et al.|Frontiers in Immunology|2022Cited by 9